age1 is a venture capital firm that focuses on early-stage (angel, pre-seed, seed, Series A) longevity biotech companies. Their strategy is to invest in founder-led teams developing therapeutics, tools, and technologies aimed at extending healthy human lifespan and shifting the paradigm from "sickcare" to health preservation.
67% of their portfolio is in Mobility & Transportation. They made 3 investments in the last 12 months. Average disclosed round size is $53.3M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$35M
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
Top Co-Investors
EQT Life Sciences1 shared
Speedinvest1 shared
BlueYard Capital1 shared
Exor Ventures1 shared
Norrsken VC1 shared
PsyMed1 shared
Baillie Gifford1 shared
Last updated: 12 April 2026